Content of phenylalanine, tyrosine and their metabolites in CSF in phenylketonuria
- PMID: 1779620
- DOI: 10.1007/BF01799945
Content of phenylalanine, tyrosine and their metabolites in CSF in phenylketonuria
Abstract
By using ion-exchange chromatography and gas chromatography coupled with mass spectrometry, the content of phenylalanine, tyrosine and their metabolites typical of phenylketonuria (PKU) was determined in the cerebrospinal fluid (CSF) of 8 untreated children with classical PKU and 9 controls. At the same time, plasma and urine were analysed. In PKU the content of phenylalanine is increased on average 23 times in plasma and CSF. The content of phenylalanine and tyrosine in CSF is about 4 times less as compared with plasma. The phenylalanine-to-tyrosine ratio is approximately the same for these fluids both in control and in PKU. This indicates that the transport of phenylalanine and tyrosine through the blood-brain barrier is not disturbed in PKU. Phenylpyruvate and 4-hydroxyphenylpyruvate are either not detected or present in very low concentrations in the CSF of children with PKU; their derivatives, phenyllactate and 4-hydroxyphenyllactate, are present in relatively higher concentrations. This indicates increased metabolic conversion in brain tissues.
Similar articles
-
Phenylalanine and other amino acids in phenylketonuria.J Inherit Metab Dis. 1993;16(6):1045-6. doi: 10.1007/BF00711525. J Inherit Metab Dis. 1993. PMID: 8127057 No abstract available.
-
On the brain barrier system function and changes of cerebrospinal fluid concentrations of phenylalanine and tyrosine in human phenylketonuria.Biomed Biochim Acta. 1984;43(2):197-204. Biomed Biochim Acta. 1984. PMID: 6732755
-
Does hyperphenylalaninemia induce brain glucose hypometabolism? Cerebral spinal fluid findings in treated adult phenylketonuric patients.Mol Genet Metab. 2024 May;142(1):108464. doi: 10.1016/j.ymgme.2024.108464. Epub 2024 Mar 23. Mol Genet Metab. 2024. PMID: 38537426
-
Impaired arachidonic (20:4n-6) and docosahexaenoic (22:6n-3) acid synthesis by phenylalanine metabolites as etiological factors in the neuropathology of phenylketonuria.Mol Genet Metab. 2001 Mar;72(3):185-98. doi: 10.1006/mgme.2001.3148. Mol Genet Metab. 2001. PMID: 11243724 Review.
-
[Phenylalanine metabolites in hyperphenylalaninemic children].An Esp Pediatr. 1992 May;36(5):371-4. An Esp Pediatr. 1992. PMID: 1616197 Review. Spanish.
Cited by
-
Phenylalanine and other amino acids in phenylketonuria.J Inherit Metab Dis. 1993;16(6):1045-6. doi: 10.1007/BF00711525. J Inherit Metab Dis. 1993. PMID: 8127057 No abstract available.
-
GluN2B suppression restores phenylalanine-induced neuroplasticity and cognition impairments in a mouse model of phenylketonuria.J Clin Invest. 2025 May 8;135(13):e184299. doi: 10.1172/JCI184299. eCollection 2025 Jul 1. J Clin Invest. 2025. PMID: 40338662 Free PMC article.
-
Blood-brain barrier transport of amino acids in healthy controls and in patients with phenylketonuria.J Inherit Metab Dis. 1995;18(6):653-64. doi: 10.1007/BF02436753. J Inherit Metab Dis. 1995. PMID: 8750601
-
1H MR chemical shift imaging detection of phenylalanine in patients suffering from phenylketonuria (PKU).Eur Radiol. 2004 Oct;14(10):1895-900. doi: 10.1007/s00330-004-2388-z. Epub 2004 Aug 3. Eur Radiol. 2004. PMID: 15378255
-
Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause?J Inherit Metab Dis. 2009 Feb;32(1):46-51. doi: 10.1007/s10545-008-0946-2. Epub 2009 Jan 13. J Inherit Metab Dis. 2009. PMID: 19191004 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical